Skip to main content
  • Register
  • Help
  • Contact us

Nephros Inc (NEPH) USD0.001

Sell:$6.63 Buy:$7.98 Change: $0.38 (4.90%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Change: $0.38 (4.90%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Change: $0.38 (4.90%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nephros, Inc. (Nephros), is a commercial-stage company that develops and sells water purification products to medical devices and commercial markets. In medical device markets, its filters are generally classified as ultrafilters, and are used primarily by hospitals for the prevention of infection from water-borne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. In commercial markets, the Company manufactures and sell filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Marketed under both the Nephros and AETHER brands. The Company’s product lines are: Water Filtration Products and Specialty Renal Products (HDF System). The Company’s subsidiary, Specialty Renal Products, Inc. (SRP), is a development-stage medical device company focused primarily on developing hemodiafiltration (HDF) technology.

Contact details

380 Lackawanna Pl
United States
+1 (201) 3435202

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$78.62 million
Shares in issue:
9.95 million
Household Appliances
United States
US dollar

Key personnel

  • Andrew Astor
    President, Chief Executive Officer, Chief Financial Officer, Director
  • Daron Evans
    Chief Executive Officer of Specialty Renal Products
  • Wes Lobo
    Chief Marketing Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.